<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36942191</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>22</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>IL-6 Serum Levels in COVID-19 Patients With Vertigo.</ArticleTitle><Pagination><StartPage>e35042</StartPage><MedlinePgn>e35042</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e35042</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.35042</ELocationID><Abstract><AbstractText>Introduction Dizziness and vertigo represent well-established symptoms of COVID-19. An overexpression of cytokines, a condition often described with the term "cytokine storm" or "hypercytokinemia", is a key characteristic of SARS-Cov-2 infection and plays a pivotal role in disease progression and prognosis. Among them, IL-6 is of major importance.&#xa0; Purpose The purpose of this study is to investigate any probable IL-6 serum titer difference in COVID-19 patients with vertigo (V+) or without vertigo (V-) admitted to the COVID-19 internal medicine departments of Attikon University Hospital, Athens, Greece, within 12 months. Methods The sample consisted of 52 COVID-19 patients who were diagnosed between January 1, 2020, and December 31, 2020. Of those, 31 reported vertigos during their admission (V+), while the remaining 21 COVID-19 patients did not complain of such symptoms (V-). Results Higher IL-6 serum levels post-COVID-19 infections lead to higher incidence rates of vertigo symptoms (p&lt;.005), regardless of gender and age (p.005).</AbstractText><CopyrightInformation>Copyright &#xa9; 2023, Kitsos et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kitsos</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Attikon University Hospital, Athens, GRC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tzartos</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Attikon University Hospital, Athens, GRC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korres</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, National and Kapodistrian University of Athens School of Medicine, Athens, GRC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giannopapas</LastName><ForeName>Vasileios</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Physical Therapy, University of West Attica, Athens, GRC.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Attikon University Hospital, Athens, GRC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riga</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology-Head and Neck Surgery, Dammam Medical Complex, Dammam, SAU.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stergiou</LastName><ForeName>Christos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Attikon University Hospital, Athens, GRC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsoga</LastName><ForeName>Anthi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Attikon University Hospital, Athens, GRC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grigoropoulos</LastName><ForeName>Christos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Attikon University Hospital, Athens, GRC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paraskevas</LastName><ForeName>Georgios</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, Attikon University Hospital, Athens, GRC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zompola</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Attikon University Hospital, Athens, GRC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nikolopoulos</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Attikon University Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, GRC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giannopoulos</LastName><ForeName>Sotirios</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Attikon University Hospital, Athens, GRC.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">covid-19</Keyword><Keyword MajorTopicYN="N">dizziness</Keyword><Keyword MajorTopicYN="N">interleukin (il)-6</Keyword><Keyword MajorTopicYN="N">long covid syndrome</Keyword><Keyword MajorTopicYN="N">vertigo</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>21</Day><Hour>2</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36942191</ArticleId><ArticleId IdType="pmc">PMC10024114</ArticleId><ArticleId IdType="doi">10.7759/cureus.35042</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jafari Z, Kolb BE, Mohajerani MH. Cambridge Core. 2022: Cambridge University Press; Hearing Loss, Tinnitus, and Dizziness in COVID-19: A Systematic Review and Meta-Analysis.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8267343</ArticleId><ArticleId IdType="pubmed">33843530</ArticleId></ArticleIdList></Reference><Reference><Citation>Dizziness and COVID-19. Saniasiaya J, Kulasegarah J. Ear Nose Throat J. 2021;100:29&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7492824</ArticleId><ArticleId IdType="pubmed">32931322</ArticleId></ArticleIdList></Reference><Reference><Citation>Covid-19-Induced Dysautonomia: A Menace of Sympathetic Storm. Al-Kuraishy HM, Al-Gareeb AI, Qusti S, Alshammari EM, Gyebi GA, Batiha GE. ASN Neuro. 2021;13:17590914211057635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8586167</ArticleId><ArticleId IdType="pubmed">34755562</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute vertigo after COVID-19 vaccination: Case series and literature review. Di Mauro P, La Mantia I, Cocuzza S, et al. Front Med (Lausanne) 2021;8:790931.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8770332</ArticleId><ArticleId IdType="pubmed">35071270</ArticleId></ArticleIdList></Reference><Reference><Citation>Benign paroxysmal positional vertigo (BPPV) in COVID-19. Picciotti PM, Passali GC, Sergi B, De Corso E. Audiol Res. 2021;11:418&#x2013;422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8395413</ArticleId><ArticleId IdType="pubmed">34449541</ArticleId></ArticleIdList></Reference><Reference><Citation>The Role of Oxidative Stress and Inflammatory Mediators in Benign Paroxysmal Positional Vertigo. G&#xfc;&#xe7;l&#xfc;t&#xfc;rk MT, &#xdc;nal ZN, &#x130;smi O, &#xc7;imen MB, &#xdc;nal M. J Int Adv Otol. 2016;12:101&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">27340993</ArticleId></ArticleIdList></Reference><Reference><Citation>Serum oxidative stress, inflammatory response and platelet activation in patients with vascular vertigo. Qian SX, Gu JX, Guan QB, Zhang XL, Wang YP. https://pubmed.ncbi.nlm.nih.gov/30945512/ J Biol Regul Homeost Agents. 2019;33:499&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pubmed">30945512</ArticleId></ArticleIdList></Reference><Reference><Citation>Proinflammatory cytokines and response to molds in mononuclear cells of patients with Meniere disease. Frejo L, Gallego-Martinez A, Requena T, et al. Sci Rep. 2018;8:5974.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5899176</ArticleId><ArticleId IdType="pubmed">29654306</ArticleId></ArticleIdList></Reference><Reference><Citation>The COVID-19 cytokine storm; what we know so far. Ragab D, Salah Eldin H, Taeimah M, Khattab R, Salem R. Front Immunol. 2020;11:1446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7308649</ArticleId><ArticleId IdType="pubmed">32612617</ArticleId></ArticleIdList></Reference><Reference><Citation>IL-6: Relevance for Immunopathology of SARS-CoV-2. Gubernatorova EO, Gorshkova EA, Polinova AI, Drutskaya MS. Cytokine Growth Factor Rev. 2020;53:13&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7237916</ArticleId><ArticleId IdType="pubmed">32475759</ArticleId></ArticleIdList></Reference><Reference><Citation>Interleukin-6 as a potential biomarker of COVID-19 progression. Ulhaq ZS, Soraya GV. Med Mal Infect. 2020;50:382&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7129451</ArticleId><ArticleId IdType="pubmed">32259560</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19: risk for cytokine targeting in chronic inflammatory diseases? Schett G, Sticherling M, Neurath MF. Nat Rev Immunol. 2020;20:271&#x2013;272.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7186927</ArticleId><ArticleId IdType="pubmed">32296135</ArticleId></ArticleIdList></Reference><Reference><Citation>Confronting the Controversy: Interleukin-6 and the COVID-19 Cytokine Storm Syndrome. Chen LY, Hoiland RL, Stukas S, Wellington CL, Sekhon MS. Eur Respir J. 2020;56</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7474149</ArticleId><ArticleId IdType="pubmed">32883678</ArticleId></ArticleIdList></Reference><Reference><Citation>SARS-CoV-2-mediated encephalitis: Role of AT2R receptors in the blood-brain barrier. de Sousa AK, Magalh&#xe3;es DA, Ferreira JD, Barbosa AL. Med Hypotheses. 2020;144:110213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7449115</ArticleId><ArticleId IdType="pubmed">33254519</ArticleId></ArticleIdList></Reference><Reference><Citation>The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Schulthei&#xdf; C, Willscher E, Paschold L, et al. Cell Rep Med. 2022;3:100663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Vestibular disorders in patients after COVID-19 infection. Pazdro-Zastawny K, Dorobisz K, Misiak P, Kruk-Krzemie&#x144; A, Zato&#x144;ski T. Front Neurol. 2022;13:956515.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9531925</ArticleId><ArticleId IdType="pubmed">36203969</ArticleId></ArticleIdList></Reference><Reference><Citation>'The long tail of Covid-19' - The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. Doykov I, H&#xe4;llqvist J, Gilmour KC, Grandjean L, Mills K, Heywood WE. F1000Res. 2020;9:1349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7745182</ArticleId><ArticleId IdType="pubmed">33391730</ArticleId></ArticleIdList></Reference><Reference><Citation>Self-reported tinnitus and vertigo or dizziness in a cohort of adult long COVID patients. Degen CV, Mikuteit M, Niewolik J, et al. Front Neurol. 2022;13:884002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9082801</ArticleId><ArticleId IdType="pubmed">35547372</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurological manifestations of long-COVID syndrome: a narrative review. Stefanou MI, Palaiodimou L, Bakola E, et al. Ther Adv Chronic Dis. 2022;13:20406223221076890.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8859684</ArticleId><ArticleId IdType="pubmed">35198136</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>